6Kiyoshi Mori,Yukari Kamiyama,Tetsuro Kondo,Yasuhiko Kano,Tetsuro Kodama.Pilot phase II study of weekly chemotherapy with paclitaxel and carboplatin for refractory or relapsed small-cell lung cancer[J].Cancer Chemotherapy and Pharmacology.2006(1) 被引量：1
7BummJr PA.Defining the role of paclitaxel in lung cancer:summary of recent studies and i mplications for future direc-tions[].Seminars in Oncology.1997 被引量：1
8O‘Brien ME,Ciuleanu T E,Tsekov H,et al.PhaseⅢtrialcomparing supportive care with oral topotecanin patients withrelapsed small-cell lung cancer[].Journal of Clinical Oncology.2006 被引量：1
9Chen G,Huynh M,ehrenbacher L,et al.Phase II trial ofirinotecan andcarboplatinfor extensive or relapsedsmall-celllung cancer[].Journal of Clinical Oncology.2009 被引量：1
10Hanna N H,Ansari R,Bhatia S,et al.Pemetrexed in pa-tients (pts)with relapsed small cell lung cancer (SCLC):AphaseⅡstudy fromthe Hoosier Oncology Group[].ASCO Meeting Abstracts.2006 被引量：1
6Govindan R, Page N, Morgensztem D,et al. Changing epidemiology of small cell lung cancer in the United States over the last 30 years : analysis of the surveillance, epidemiologic, and end results database[J]. J Clin Oncol,2006,24(28) :4539-4544. 被引量：1
7Takada M , Fukuoka M , Kawahara M , et al. Phase Ⅲ study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer:results of the japan clinical oncology group study 9104 [ J]. J Clin Oncol,2002,20(14) :3054-3060. 被引量：1
8De Ruysscher D , Pijls - Johannesma M , Bentzen SM , et al. Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited disease small-cell lung cancer [ J ]. J Clin Oncol, 2006,24 ( 7 ) : 1057-1063. 被引量：1
9Stupp R, Monnerat C, Turrise A ,et al. Small cell lung cancer:state of the art and future perspectives [ J ]. Lung Cancer, 2004,45 (1) : 105-117. 被引量：1
10Murray N ,Turrisi AT. A review of first-line treatment for small cell lung cancer[ J]. J Thorac Oncol,2006,1 ( 3 ) :270-278. 被引量：1
